STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the fourth ...

Swiss biotech Bioversys AG shares started trading at 36.5 Swiss francs ($40.29) on the SIX Swiss Exchange on Friday, slightly up from the final price for its initial public offering (IPO) of 36 Swiss ...

Swiss Prime Site has brought the 2024 financial year to a successful close and, due to higher rents, a strong increase in income from Asset Management and operational improvements, achieves a ...

Save for a very brief while at the start, the Switzerland market languished in negative territory on Tuesday with investors largely ...

Key factors for dividend stock selection include company stability and the ability to grow payouts over time. Key findings are powered by ChatGPT and based solely off the content from this article.

The S&P 500 slipped after the Federal Reserve left interest rates unchanged in its first policy decision of 2025, while ...

ZURICH (Reuters) - The Swiss government said on Wednesday that it would from May 1 remove the European Union from a list of jurisdictions affected by protective measures for the Swiss stock exchange, ...

Swiss biopharma company BioVersys said on Wednesday it had launched an initial public offering on the SIX stock exchange priced at 36 Swiss francs ($39.84) per share.

For many years, the New York Islanders were a hockey team, if not without a home, without the kind of home its owners wanted.

That’s because it’s gradually dawning on investors that they no longer can count on lower interest rates and inflation to support higher stock and bond prices. They are realizing that ...